Doç. Dr. Güliz Erdem
Ad Soyad : GÜLİZ ERDEM
Unvan : Doç.Dr.
Tıbbi Birim : Kardiyoloji
Uzmanlık : Kardiyoloji
Şube : International Hastanesi
E-Posta : guliz.erdem@acibadem.com.tr
Web Sitesi :
EĞİTİM
2015 London School of Hygiene & Tropical Medicine, University of London
2006 Gazi Üniversitesi Tıp Fakültesi Kardiyoloji
1999 Hacettepe Üniversitesi Tıp Fakültesi
İŞ DENEYİMİ
2014 - Halen Acıbadem Sağlık Grubu
2012 - 2014 Memorial Şişli Hastanesi, İstanbul
2009 - 2012 Clinical Trials and Evaluation Unit, Royal Brompton Hospital, London, Imperial College, United Kingdom
2007 - Ankara Yüksek İhtisas Eğitim ve Araştırma Hastanesi
2006 - 2008 Kırıkkale Yüksek İhtisas Hastanesi
2004 - Cleveland Clinic Foundation, Ohio, USA
2000 - 2006 Gazi Üniversitesi Tıp Fakültesi Kardiyoloji Anabilim Dalı
ÜYELİKLER
Türk Tabipler Birliği
Türk Kardiyoloji Derneği
European Society of Cardiology Heart Failure Association
European Society of Cardiology Working Group on Grown-up Congenital Heart Disease
European Society of Cardiology (Fellow)
BİLİMSEL YAYINLAR
Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaboration.
American Heart Journal (online 12 Feb 2014) Pitcher A, Emberson J, Lacro RV et al.
Severe hypokalemia probably associated with sertraline use.
Ann Pharmacother. 2014 Feb;48(2):297-300 Izgi C, Erdem G, Mansuroglu D, Kurtoglu N, Kara M, Gunesdogdu F.
Beta-Blockers in Heart Failure Collaborative Group. Individual patient data meta-analysis of beta-blockers in heart failure: rationale and design.
Syst Rev. 2013 Jan 18;2:7 Kotecha D, Manzano L, Altman DG, Krum H, Erdem G, Williams N, Flather MD
Rates and causes of death from non-ST elevation acute coronary syndromes: ten year follow-up of the PRAIS-UK registry.
Int J Cardiol. 2013 Sep 20;168(1):490-4 Erdem G, Bakhai A, Taneja AK, Collinson J, Banya W, Flather MD.
A prospective, randomized, placebo-controlled, double-blind, multicenter study of the effects of irbesartan on aortic dilatation in Marfan syndrome (AIMS trial): study protocol.
Trials. 2013 Dec 1;14:408 Mullen MJ, Flather MD, Jin XY, Newman WG, Erdem G, Gaze D, Valencia O, Banya W, Foley CE, Child A.
How should I treat an ostial thrombotic occlusion of the right coronary artery in the setting of an acute myocardial infarction?
EuroIntervention. 2012 Jun 20;8(2):282-9 Izgi C, Feray H, Erdem G, Bakal RB, de Smet B, Pundziute G, Mamas MA.
Assessing bleeding risk in acute coronary syndromes.
Rev Esp Cardiol (Engl Ed). 2012 Jan;65(1):4-6 Erdem G, Flather M.
What goes into a major acute coronary syndrome trial and what will future trials look like?
Curr Cardiol Rep. 2010 Jul;12(4):348-55 Erdem G, Geisler T, Flather MD.
Thrombolysis in myocardial infarction frame count in coronary arteries without visible atherosclerosis incoronary angiography of patients with stable coronary artery disease.
Saudi Med J. 2009 Jun;30(6):817-20 Tacoy GA, Yazici GE, Kocaman SA, Ozdemir MH.
The optimal time of elective percutaneous coronary intervention for stable patients after ST elevation myocardial infarction.
Angiology. 2009 Feb-Mar;60(1):67-73 Yazici GE, Erden M, Tacoy GA, Yavuz BB, Turkoglu S, Timurkaynak T.
